JPS562917A - Stabilization of sulfonated immunoglobulin - Google Patents

Stabilization of sulfonated immunoglobulin

Info

Publication number
JPS562917A
JPS562917A JP7673479A JP7673479A JPS562917A JP S562917 A JPS562917 A JP S562917A JP 7673479 A JP7673479 A JP 7673479A JP 7673479 A JP7673479 A JP 7673479A JP S562917 A JPS562917 A JP S562917A
Authority
JP
Japan
Prior art keywords
sulfonated
stabilization
immoglobulin
stabilize
increase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP7673479A
Other languages
English (en)
Japanese (ja)
Other versions
JPS6220965B2 (de
Inventor
Tsunemasa Yoshida
Shoji Ono
Yuji Fukumoto
Yoshio Ishimoto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chemo Sero Therapeutic Research Institute Kaketsuken
Teijin Ltd
Original Assignee
Chemo Sero Therapeutic Research Institute Kaketsuken
Teijin Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chemo Sero Therapeutic Research Institute Kaketsuken, Teijin Ltd filed Critical Chemo Sero Therapeutic Research Institute Kaketsuken
Priority to JP7673479A priority Critical patent/JPS562917A/ja
Publication of JPS562917A publication Critical patent/JPS562917A/ja
Publication of JPS6220965B2 publication Critical patent/JPS6220965B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
JP7673479A 1979-06-20 1979-06-20 Stabilization of sulfonated immunoglobulin Granted JPS562917A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP7673479A JPS562917A (en) 1979-06-20 1979-06-20 Stabilization of sulfonated immunoglobulin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP7673479A JPS562917A (en) 1979-06-20 1979-06-20 Stabilization of sulfonated immunoglobulin

Publications (2)

Publication Number Publication Date
JPS562917A true JPS562917A (en) 1981-01-13
JPS6220965B2 JPS6220965B2 (de) 1987-05-11

Family

ID=13613808

Family Applications (1)

Application Number Title Priority Date Filing Date
JP7673479A Granted JPS562917A (en) 1979-06-20 1979-06-20 Stabilization of sulfonated immunoglobulin

Country Status (1)

Country Link
JP (1) JPS562917A (de)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58192830A (ja) * 1982-05-04 1983-11-10 Teijin Ltd 血小板減少症治療剤
US6165467A (en) * 1991-07-20 2000-12-26 Yoshihide Hagiwara Stabilized human monoclonal antibody preparation

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58192830A (ja) * 1982-05-04 1983-11-10 Teijin Ltd 血小板減少症治療剤
US6165467A (en) * 1991-07-20 2000-12-26 Yoshihide Hagiwara Stabilized human monoclonal antibody preparation

Also Published As

Publication number Publication date
JPS6220965B2 (de) 1987-05-11

Similar Documents

Publication Publication Date Title
RU93046317A (ru) Хиндроитиназа, способ ее получения и содержание ее фармацевтические композиции
EP0270025A3 (en) Process for the preparation of an intravenously administrable immunoglobulin stable in the liquid phase
KR900005987A (ko) 일부민 제제 및 이의 제조방법
EP0421309A3 (en) Improvements in or relating to organic compounds
GR3003631T3 (de)
CA2037884A1 (en) Stabilized gonadotropin containing preparations
ATE866T1 (de) Immunserumglobulin (isg)-praeparate und verfahren zu ihrer herstellung.
NO922953D0 (no) Rekombinant fremstilt blodfaktorer og fremgangsmaate for ekspresjon av blodfaktorene, samt vacciniavirusrekombinanter
DE3261832D1 (en) Method for the stabilisation of peroxidase in a liquid medium, and the stabilised medium so obtained
JPS562917A (en) Stabilization of sulfonated immunoglobulin
IE791033L (en) Stabilised milk compositions
KR860003825A (ko) 안정한 현탁액 제조용 고체 약물제형의 제조방법
AU679581B2 (en) Method of stabilizing protein C or activated protein C and stabilized composition
EP0258111A3 (de) Neuronotrophischer Faktor
GB941019A (en) Improvements in and relating to the stability of anti-haemophilic globulin (factor viii)
EP0327769A3 (de) Neuronotrophischer Faktor
KR910016347A (ko) C형 간염 바이러스에 대한 초면역 글로블린 및 이의 제조방법
Wolkoff et al. Purification of ligandin by affinity chromatography on sulfobromophthalein-agarose gel
Okuyama Mechanism of increase of the cerebrospinal fluid (CSF) protein content in Guillain-Barre syndrome. Study using RISA in evaluation of diffusion within CSF cavity and transport of CSF to circulating plasms
GB1486787A (en) Process for stabilizing protein containing liquids
Williams et al. Pasteurization of C1 Inactivator in the Presence of Citrate Salts 1, 2
廖晓昕 Stability, boundedness, dissipation of partial variables for nonlinear systems with separating variables
EP0063353A3 (de) Hochgereinigte informatorische Ribonukleinsäure (i-RNS), Verfahren zur Herstellung und Verwendung derselben
Kosovinc Constitution of the Cd--Sn--Sb System
Lagrue et al. Lymphokine'skin reactive factor'(SRF) and the nephrotic syndrome